NYMC Faculty Publications
Identification of a Kavain Analog with Efficient Anti-inflammatory Effects
DOI
10.1038/s41598-019-49383-8
Journal Title
Scientific Reports
First Page
12940
Document Type
Article
Publication Date
September 2019
Department
Pharmacology
Abstract
Kavain, a compound derived from Piper methysticum, has demonstrated anti-inflammatory properties. To optimize its drug properties, identification and development of new kavain-derived compounds was undertaken. A focused library of analogs was synthesized and their effects on Porphyromonas gingivalis (P. gingivalis) elicited inflammation were evaluated in vitro and in vivo. The library contained cyclohexenones (5,5-dimethyl substituted cyclohexenones) substituted with a benzoate derivative at the 3-position of the cyclohexanone. The most promising analog identifed was a methylated derivative of kavain, Kava-205Me (5,5-dimethyl-3-oxocyclohex-1-en-1-yl 4-methylbenzoate.) In an in vitro assay of anti-inflammatory effects, murine macrophages (BMM) and THP-1 cells were infected with P. gingivalis (MOI = 20:1) and a panel of cytokines were measured. Both cell types treated with Kava-205Me (10 to 200 mug/ml) showed significantly and dose-dependently reduced TNF-alpha secretion induced by P. gingivalis. In BMM, Kava-205Me also reduced secretion of other cytokines involved in the early phase of inflammation, including IL-12, eotaxin, RANTES, IL-10 and interferon-gamma (p < 0.05). In vivo, in an acute model of P. gingivalis-induced calvarial destruction, administration of Kava-205Me significantly improved the rate of healing associated with reduced soft tissue inflammation and osteoclast activation. In an infective arthritis murine model induced by injection of collagen-antibody (ArthriomAb) + P. gingivalis, administration of Kava-205Me was able to reduce efficiently paw swelling and joint destruction. These results highlight the strong anti-inflammatory properties of Kava-205Me and strengthen the interest of testing such compounds in the management of P. gingivalis elicited inflammation, especially in the management of periodontitis.
Recommended Citation
Huck, O., Han, X., Mulhall, H., Gumenchuk, I., Cai, B., Panek, J., Iyer, R., & Amar, S. (2019). Identification of a Kavain Analog with Efficient Anti-inflammatory Effects. Scientific Reports, 9 (1), 12940. https://doi.org/10.1038/s41598-019-49383-8
